AVITA MEDICAL (AVMXY)
AVMXY moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How AVMXY actually reacts to news — the realized, point-in-time move the market made, measured across 160 labeled events over its full measured history with zero look-ahead.
AVMXY’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 35% | 156 |
| 30-min | 0.00% | 46% | 157 |
| 60-min | 0.00% | 47% | 157 |
| to close | 0.00% | 48% | 159 |
| Middle 50% of AVMXY reactions | -1.17% to +1.11% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 160 |
Half of all AVITA MEDICAL news events land between -1.17% and +1.11% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when AVMXY moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to AVMXY's baseline. Nothing else.
Recent AVMXY events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference | Press release | GlobeNewswire | +2.75% | +0.37% | |
| Form S-8 AVITA Medical, Inc. | SEC filing · Form S-8 | SEC EDGAR | +2.64% | +4.58% | |
| AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes | Press release | GlobeNewswire | -0.69% | +24.05% | |
| Form 8-K AVITA Medical, Inc. For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | -0.50% | +0.99% | |
| AVITA Medical to Host Investor Webinar Briefing | Press release | GlobeNewswire | -2.01% | — | |
| AVITA Medical Announces Participation at Canaccord Genuity Growth Conference | Press release | GlobeNewswire | +8.35% | +29.72% | |
| AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven | Press release | GlobeNewswire | +8.35% | +29.72% | |
| Form 10-Q AVITA Medical, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +8.35% | +29.72% | |
| Form 8-K AVITA Medical, Inc. For: Aug 06 | SEC filing · Form 8-K | SEC EDGAR | +8.35% | +29.72% | |
| Form 8-K/A AVITA Medical, Inc. For: Jun 03 | SEC filing · Form 8-K | SEC EDGAR | +8.35% | +29.72% | |
| AVITA Medical to Announce Second Quarter 2026 Financial Results | Press release | GlobeNewswire | +0.74% | +16.79% | |
| AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting | Press release | GlobeNewswire | +1.75% | +0.00% | |
| Form 8-K AVITA Medical, Inc. For: Jun 05 | SEC filing · Form 8-K | SEC EDGAR | -1.41% | -2.58% | |
| Form 8-K AVITA Medical, Inc. For: Jun 03 | SEC filing · Form 8-K | SEC EDGAR | +1.07% | +3.81% | |
| AVITA Medical to Host Investor Webinar Briefing | Press release | GlobeNewswire | -4.42% | -7.30% | |
| AVITA Medical Reports First Quarter 2026 Financial Results | Press release | GlobeNewswire | +12.88% | -2.15% | |
| Form 10-Q AVITA Medical, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +12.88% | -2.15% | |
| Form 8-K AVITA Medical, Inc. For: May 14 | SEC filing · Form 8-K | SEC EDGAR | +12.88% | -2.15% | |
| Form 8-K AVITA Medical, Inc. For: Apr 30 | SEC filing · Form 8-K | SEC EDGAR | +1.13% | -3.39% | |
| AVITA Medical Names Cary Vance as Chief Executive Officer | Press release | GlobeNewswire | +3.29% | +1.41% | |
| AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO | Press release | GlobeNewswire | +3.29% | +1.41% | |
| AVITA Medical to Announce First Quarter 2026 Financial Results | Press release | GlobeNewswire | -2.07% | +2.53% | |
| Form DEF 14A AVITA Medical, Inc. For: Apr 22 | SEC filing · Form DEF | SEC EDGAR | -0.21% | -7.28% | |
| AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association | Press release | GlobeNewswire | +0.09% | -7.36% | |
| AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting | Press release | GlobeNewswire | -0.10% | +14.52% | |
| Form EFFECT AVITA Medical, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +0.76% | +8.91% | |
| AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness | Press release | GlobeNewswire | +1.82% | +9.93% | |
| Form PRE 14A AVITA Medical, Inc. For: Apr 08 | SEC filing · Form PRE | SEC EDGAR | +1.82% | +9.93% | |
| AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data | Press release | GlobeNewswire | -0.49% | +0.49% | |
| Form S-3 AVITA Medical, Inc. | SEC filing · Form S-3 | SEC EDGAR | +2.68% | +1.07% | |
| AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference | Press release | GlobeNewswire | +0.00% | +11.13% | |
| AVITA Medical to Host Investor Webinar Briefing | Press release | GlobeNewswire | +2.73% | +13.66% | |
| AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results | Press release | GlobeNewswire | +2.73% | +13.66% | |
| Form 10-K AVITA Medical, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +2.73% | +13.66% | |
| Form 8-K AVITA Medical, Inc. For: Feb 12 | SEC filing · Form 8-K | SEC EDGAR | +2.73% | +13.66% | |
| Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies | Press release | GlobeNewswire | -1.43% | +1.80% | |
| AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook | Press release | GlobeNewswire | +0.00% | -2.94% | |
| Form 8-K AVITA Medical, Inc. For: Jan 13 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.94% | |
| AVITA Medical Announces Changes to its Board of Directors | Press release | GlobeNewswire | -0.58% | +0.00% | |
| Form 8-K AVITA Medical, Inc. For: Jan 01 | SEC filing · Form 8-K | SEC EDGAR | -0.58% | +0.00% | |
| AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference | Press release | GlobeNewswire | +2.25% | +1.47% | |
| AVITA Medical to Present at the Piper Sandler 37?? Annual Healthcare Conference | Press release | GlobeNewswire | +0.00% | -0.79% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating AVITA Medical, Inc. (RCEL) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | -0.27% | — | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against AVITA Medical, Inc. (RCEL) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | -0.53% | +0.27% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against AVITA Medical, Inc. (RCEL) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | -0.13% | +2.72% | |
| AVITA Medical to Host Investor Webinar Briefing | Press release | GlobeNewswire | +3.15% | +4.20% | |
| AVITA Medical, Inc. (RCEL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.15% | +11.37% | |
| AVITA® Medical Reports Third Quarter 2025 Financial Results | Press release | GlobeNewswire | +0.00% | +11.87% | |
| Form 10-Q AVITA Medical, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +11.87% | |
| Form 8-K AVITA Medical, Inc. For: Nov 05 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +11.87% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the AVMXY section they belong to.
Where else AVMXY is measured.
AVMXY earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| NanoVibronix, Inc. (NAOV) | 161 | -0.40% | 39% |
| Zomedica Corp. Common Shares (ZOM) | 161 | +0.08% | 53% |
| Adaptimmune Therapeutics plc - American Depositary Shares (ADAP) | 159 | -1.17% | 27% |
| DURECT Corporation (DRRX) | 159 | +0.03% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is AVITA MEDICAL's median reaction calculated?
Every labeled AVMXY news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 160 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 46% of AVMXY's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does AVMXY's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.